From thermal stability screening with SUPR-DSF, to secondary structure analysis with the Chirascan V100, and reaction kinetics with the SX20, our systems deliver the data you need to move biologics forward.
Festival of Biologics
30th September – 2nd October 2025
Join Nicoya and Applied Photophysics at Festival of Biologics!
The Festival of Biologics Basel is Europe’s largest biologics event, covering the start-to-finish of the industry in antibody therapies, cell and gene therapies, immunotherapies and biosimilars. Designed for industry experts in pharma and biotech, start-ups, academics, regulators and investors, the Festival of Biologics is the meeting place for the large molecule therapy ecosystem, bringing together 3000+ global audiences.
Join 350 world class speakers in exploring the latest research in early stage discovery, modality engineering, translational medicine, clinical trials, manufacturing, commercialisation and fill/finish operations across key therapy and disease areas. With three days of presentations, panels, roundtables and workshops, this event is the place to be to keep up with the latest advances across the entire biologics and ATMP value chain.
Come and talk to our team at booth 151 to discuss how our technologies, like SPR, circular dichroism (CD), stopped-flow kinetics, and SUPR-DSF, can accelerate your biologics discovery and development.
Come and talk to our team at booth 151 to discuss how our technologies, like SPR, circular dichroism (CD), stopped-flow kinetics, and SUPR-DSF, can accelerate your biologics discovery and development.
Key topics on the agenda:
- AI and Machine Learning in Oncology and Biomarkers
- Antibodies in Immunotherapy
- Armed Antibodies
- Biosimilar Development, Manufacturing and Analysis
- Biosimilars in Healthcare Policy
- Checkpoint Inhibitors
- Clinical Trials
- CMC, Developability and Manufacturability
- Commercialization and Market Access
- Commercialization of Biosimilars and Sustainability of the Industry
- Neoantigens
- New Technology in Screening and Analytics for Antibody Proteins
- Non-Oncology Immunotherapy
- Novel Indications for Therapeutic Antibodies
- Oncolytic Viruses
- The Clinical Environment and Real-world Evidence
- Tumor Microenvironment
- Value and affordability of Biosimilars
Our Products
